Matthew A. Croxen
- Endocrinology top 0.1%
- Escherichia coli research studies 16
- Vibrio bacteria research studies 10
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 9
- Infectious Diseases top 1%
- Viral gastroenteritis research and epidemiology 8
- SARS-CoV-2 and COVID-19 Research 7
- Food Science top 1%
- Salmonella and Campylobacter epidemiology 9
- Biotechnology top 5%
-
- Streptococcal Infections and Treatments 6
-
- Gut microbiota and health 6
- Co-authors
- B. Brett FinlayRoland W. ScholzKristie M. KeeneyMarta WlodarskaPaul S. HoffmanGary SissonBenjamin P. WillingNunilo Cremades
- Journals
- Journal of Bacteriology (5 papers)Infection and Immunity (4 papers)Eurosurveillance (4 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Matthew A. Croxen
54 papers receiving 3.5k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Endocrinology 1.6k
- Molecular Medicine 521
- Infectious Diseases 1.3k
- Food Science 828
- Biotechnology 180
Countries citing papers authored by Matthew A. Croxen
This map shows the geographic impact of Matthew A. Croxen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Croxen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Croxen more than expected).
Fields of papers citing papers by Matthew A. Croxen
This network shows the impact of papers produced by Matthew A. Croxen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Croxen. The network helps show where Matthew A. Croxen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew A. Croxen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 22 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 24 | |
| 7 | 2021 | 13 | |
| 8 | 2021 | 3 | |
| 9 | 2019 | 11 | |
| 10 | 2019 | 13 | |
| 11 | 2016 | 62 | |
| 12 | 2016 | 10 | |
| 13 | 2015 | 6 | |
| 14 | 2014 | 71 | |
| 15 | 2011 | 46 | |
| 16 | 2011 | 145 | |
| 17 | 2011 | 136 | |
| 18 | Molecular mechanisms of Escherichia coli pathogenicitybreakdown → | 2009 | 841 |
| 19 | 2009 | 60 | |
| 20 | 2006 | 197 |
About Matthew A. Croxen
Matthew A. Croxen is a scholar working on Endocrinology, Molecular Medicine and Infectious Diseases, having authored 57 papers that have together received 3.6k indexed citations. Recurring topics across this work include Escherichia coli research studies (16 papers), Vibrio bacteria research studies (10 papers), Salmonella and Campylobacter epidemiology (9 papers), Antibiotic Resistance in Bacteria (9 papers), Viral gastroenteritis research and epidemiology (8 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Streptococcal Infections and Treatments (6 papers) and Gut microbiota and health (6 papers). The work is most often cited by research in Endocrinology (1.6k citations), Molecular Medicine (521 citations) and Infectious Diseases (1.3k citations). Matthew A. Croxen has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include B. Brett Finlay, Roland W. Scholz, Kristie M. Keeney, Marta Wlodarska, Paul S. Hoffman, Gary Sisson, Benjamin P. Willing, Nunilo Cremades, Roberto G. Melano and Rosana B. R. Ferreira. Their work appears in journals such as Journal of Bacteriology, Infection and Immunity, Eurosurveillance, PLoS ONE and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.